Disruption of overshadowing and latent inhibition in high schizotypy individuals

Behavioural Brain Research

Volumn 233, Issue 1, 2012, Pages 201-208

  Granger, K T ^a,b   Prados, J ^a   Young, A M J ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Latent inhibition; Overshadowing; Schizotypy; Selective attention

Indexed keywords

ADULT; ARTICLE; ATTENTION DISTURBANCE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; LATENT INHIBITION; MALE; MENTAL PERFORMANCE; MENTAL TASK; OVERSHADOWING; OXFORD LIVERPOOL INVENTORY OF FEELINGS AND EXPERIENCE; PRIORITY JOURNAL; PSYCHOTICISM SCORE; REPRODUCIBILITY; SCHIZOTYPAL PERSONALITY DISORDER; SCORING SYSTEM; SELECTIVE ATTENTION; SYMPTOM; UNDERGRADUATE STUDENT; VALIDATION STUDY;

ANALYSIS OF VARIANCE; ATTENTION; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; FEMALE; HUMANS; INHIBITION (PSYCHOLOGY); LEARNING; MALE; NEUROPSYCHOLOGICAL TESTS; PERSONALITY INVENTORY; REACTION TIME; REGRESSION ANALYSIS; SCHIZOTYPAL PERSONALITY DISORDER; STUDENTS; UNIVERSITIES;

EID: 84861725797     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2012.05.003     Document Type: Article

References (38)

1. Mackintosh N.J. Overshadowing and stimulus intensity. Animal Learning and Behavior 1976, 4:186-192.
2. Lubow R.E. Latent inhibition. Psychological Bulletin 1973, 79:390-407.
3. Baruch I., Hemsley D.R., Gray J.A. Differential performance of acute and chronic schizophrenics in a latent inhibition task. Journal of Nervous and Mental Disease 1988, 176:598-606.
4. Gray N.S., Hemsley D.R., Gray J.A. Abolition of latent inhibition in acute, but not chronic, schizophrenics. Neurology and Psychiatric Brain Research 1992, 1:83-89.
5. Gray N.S., Pilowsky L.S., Gray J.A., Kerwin R.W. Latent inhibition in drug naive schizophrenics: relationship to duration of illness and dopamine D2 binding using SPET. Schizophrenia Research 1995, 17:95-107.
6. Kathmann N., von Recum S., Haag C., Engel R.R. Electrophysiological evidence for reduced latent inhibition in schizophrenic patients. Schizophrenia Research 2000, 45:103-114.
7. Lubow R.E., Kaplan O., Abramovich P., Rudnick A., Laor N. Visual search in schizophrenia: latent inhibition and novel pop-out effects. Schizophrenia Research 2000, 45:145-156.
8. Rascle C., Mazas O., Vaiva G., Tournant M., Raybois O., Goudemand M., et al. Clinical features of latent inhibition in schizophrenia. Schizophrenia Research 2001, 51:149-161.
9. Swerdlow N.R., Braff D.L., Hartston H., Perry W., Geyer M.A. Latent inhibition in schizophrenia. Schizophrenia Research 1996, 20:91-103.
10. Williams J.H., Wellman N.A., Geaney D.P., Cowen P.J., Feldon J., Rawlins J.N.P. Reduced latent inhibition in people with schizophrenia: an effect of psychosis or of its treatment. British Journal of Psychiatry 1998, 172:243-249.
11. Gray J.A., Feldon J., Rawlins J.N.P., Hemsley D.R., Smith A.D. The neuropsychology of schizophrenia. Behavioural Brain Science 1991, 14:1-20.
12. Moser P.C., Hitchcock J.M., Lister S., Moran P.M. The pharmacology of latent inhibition as an animal model of schizophrenia. Brain Research Reviews 2000, 33:275-307.
13. Weiner I. The two-headed latent inhibition model of schizophrenia: modeling positive and negative symptoms and their treatment. Psychopharmacology 2003, 169:257-297.
14. O'Tuathaigh C.M.P., Salum C., Young A.M.J., Pickering A.D., Joseph M.H., Moran P.M. The effect of amphetamine on Kamin blocking and overshadowing. Behavioural Pharmacology 2003, 14:315-322.
15. Claridge G. Schizotypy: implications for illness and health 1997, Oxford University Press, Oxford.
16. Verdoux H., van Os J. Psychotic syndromes in non-clinical populations and the continuum of psychosis. Schizophrenia Research 2002, 54:59-65.
17. Burch G.J., Hemsley D.R., Pavelis C., Corr P.J. Personality, creativity and latent inhibition. European Journal of Personality 2006, 20:107-122.
18. Baruch I., Hemsley D.R., Gray J.A. Latent inhibition and psychosis proneness in normal subjects. Personality and Individual Differences 1988, 9:777-783.
19. Lubow R.E., Inberg-Sachs Y., Zalstein-Orda N., Gerwitz J.C. Latent inhibition in low and high psychosis prone normal subjects. Personality and Individual Differences 1992, 13:563-572.
20. Braunstein-Bercovitz H., Rammsayer T., Gibbons H., Lubow R.E. Latent inhibition deficits in high-schizotypal normals: symptom-specific or anxiety-related?. Schizophrenia Research 2002, 53:109-121.
21. Lubow R.E. Latent inhibition as a measure of learned inattention: some problems and solutions. Behavioural Brain Research 1997, 88:75-83.
22. De la Casa L.G., Lubow R.E. Latent inhibition with a response time measure from a within-subject design: effects of number of preexposures, masking task, context change, and delay. Neuropsychology 2001, 15:244-253.
23. Gray N.S., Snowden R.J., Peoples M., Hemsley D.R., Gray J.A. A demonstration of within-subjects latent inhibition in the human: limitationsand advantages. Behavioural Brain Research 2003, 138:1-8.
24. Shrira A., Kaplan O. Latent inhibition in within-subject designs: the roles of masking, schizotypy and gender. Personality and Individual Differences 2009, 47:922-927.
25. Evans L.H., Gray N.S., Snowden R.J. A new continuous within-participants latent inhibition task: examining associations with schizotypy dimensions, smoking status and gender. Biological Psychology 2007, 74:365-373.
26. Mason O., Claridge G., Jackson M. New scales for the assessment of schizotypy. Personality and Individual Differences 1995, 18:7-13.
27. Mason O., Claridge G. The Oxford-Liverpool Inventory of Feelings and Experiences (O-LIFE): further description and extended norms. Schizophrenia Research 2006, 82:203-211.
28. Gray N.S., Fernandez M., Williams J., Ruddle R.A., Snowden R.J. Which schizotypal dimensions abolish latent inhibition?. British Journal of Clinical Psychology 2002, 41:271-284.
29. Prados J. Blocking and overshadowing in human geometry learning. Journal of Experimental Psychology: Animal Behaviour Processes 2011, 37:121-126.
30. Prados J., Alvarez B., Reynolds G. Spatial integration in human geometry learning. Behavioural Brain Research 2011, 224:297-304.
31. Young A.M.J., Kumari V., Mehrotra R., Hemsley D.R., Andrew C., Sharma T., et al. Disruption of learned irrelevance in acute schizophrenia in a novel continuous within-subject paradigm suitable for fMRI. Behavioural Brain Research 2005, 156:277-288.
32. Cochrane M., Petch I., Pickering A.D. Do measures of schizotypal personality provide non-clinical analogues of schizophrenic symptomatology?. Psychiatry Research 2010, 176:150-154.
33. Lubow R.E. The construct validity of the animal latent inhibition model of selective attention deficits in schizophrenia. Schizophrenia Bulletin 2005, 31:139-153.
34. Escobar M., Arcediano F., Miller R.R. Latent inhibition in human adults without masking. Journal of Experimental Psychology: Learning, Memory, and Cognition 2003, 29:1028-1040.
35. Lubow R.E., De la Casa G. Latent inhibition as a function of schizotypality and gender: implications for schizophrenia. Biological Psychology 2002, 59:69-86.
36. Lubow R.E., Gerwitz J.C. Latent inhibition in humans: data, theory, and implications for schizophrenia. Psychological Bulletin 1995, 117:87-103.
37. O'Tuathaigh C.M.P., Moran P.M. Evidence for dopamine D1 receptor involvement in the stimulus selection task: overshadowing in the rat. Psychopharmacology 2002, 162:225-231.
38. Vaitl D., Lipp O.V., Bauer U., Schuler G., Stark R., Zimmerman M., et al. Latent inhibition and schizophrenia: Pavlovian conditioning of autonomic response. Schizophrenia Research 2002, 55:147-158.